M IHTESHAM JANJUA: Open Payments
NPI 1740268317 · COLLEGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 62 payments from 10 companies in 2025. Trend: 2023 $757 · 2024 $634 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $353 |
| Neurocrine BioSciences, Inc. | 14 | $305 |
| Medtronic, Inc. | 1 | $161 |
| Lundbeck LLC | 6 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $116 |
| Alkermes, Inc. | 4 | $104 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $52 |
Products named: REXULTI, INGREZZA, INCEPTIV, CAPLYTA, FANAPT, LYBALVI, SPRAVATO, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
